Scaling Biocatalytic Processes from Conceptualization to Industrial Application
Based in Nuth, The Netherlands, Aminoverse was established in 2020 with a 200 m² wet lab. This Contract Research Organization (CRO) specializes in enzyme-dedicated research and has quickly made a name for itself in the pharmaceutical, flavors & fragrances, and agrochemicals industries, serving over 50 global companies.
Aminoverse operates on a fee-for-service model, ensuring that clients retain full Intellectual Property rights and are not burdened with royalties. The organization's unique approach has led to a significant increase in success chances by 10-fold and a reduction in R&D spend by up to 75%.
One of Aminoverse's key strengths lies in its use of three AI-augmented platforms: EnzyNAV AI, EnzyMAP AI, and EnzyREC AI. These tools enable the organization to excel in discovering the right enzyme and designing the optimal enzyme, integrating wet lab, biophysics, and AI.
In 2021, Aminoverse launched its product-based business with the introduction of hydroxylation enzyme kits. The following year, they successfully applied EnzyMAP AI in a client project, demonstrating the effectiveness of their innovative approach.
Aminoverse's team of 20 interdisciplinary professionals fosters close collaboration through weekly updates and open communication. They have supported a diverse range of industries, including gaming, biotechnology, pharmaceuticals, and film production.
Looking to the future, Aminoverse plans to diversify its ready-to-use enzyme panels and establish a platform for de novo enzyme design by 2025. Their ultimate goal is to develop enzymatic processes that truly make a difference.
Remarkably, Aminoverse reached profitability just 3.5 years after its inception without the need for venture capital funding. This testament to their business model's efficiency and the demand for their services has positioned Aminoverse as a leader in the enzyme research industry.
